2Poykko SM, Kellokoski E, Horkko S, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes [ J ]. Diabetes, 2003, 52 (10) :2546 - 2553.
3Fagerberg B, Huhen LM, ltuhhe J. Plasma ghrelin, body fat, insulin resistance, and smoking in elinieally healthymen: the atheroselerosis and insulin resistance study[ J ]. Metabolism, 2003, 52 ( 11 ) : 1460 - 1463.
4Torsello A, Breseiani E, Rossoni G, et al. Ghrelin plays a minor role in tile physiological control of cardiac function in the rat[J]. Endocrinologl 2003, 144(5) : 1787 - 1792.
5Shimizu Y, Nagaya N, Teranishi Y, et al. Ghrelin improves endothelial dysfunclion through growth hormone-independent mechanisms in rats[ J ]. Biochem Biophys Res Comrrtun, 2003, 310 ( 3 ) : 830 - 835.
6Bedendi I, Alloatti G, Marcantoni A, et al. Cardiac elects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Glnl 4- ghrelin [ J I. Ear J Pharmacol, 2003, 476 ( 1 - 2) :87 - 95.
7Li WG, Gaxrila D, Liu XB. Ghrelin inhibits proinflammatory responses and nuclear factor-KB activation in human endothelial cells [J]. Circulation, 2004, 109(18) :2221 -2226.
8Skilton MR, Nakhla S, Sieveking DP, et al. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells [ J ]. Clin Exp Pharmacol Physiol, 2005, 32 (10) :839 - 844.
9Suematsu M, Katsuki A, Sumida Y, et al. Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects [ J ]. Eur J Endocrinol, 2005, 153 ( 3 ) :403 - 407.
10Fontenot E, DeVente JE, Seidel ER. Obestatin and ghrelin in obese and in pregnant women [ J]. Peptides, 2007, 28 (10) : 1937 - 1944.
